PPA2 and prostate carcinoma: While few studies have directly assessed the relationship between PPA2 and risk of prostate cancer prospectively, a proteomic tissue analysis comparing men with localised prostate cancer to men with lymph node metastasised prostate cancer found significantly higher levels of PPA2 in men with the more advanced disease.51